Tradestie Institutional Equity Comparison Engine

STEM vs DNA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DNA Overall Edge

DNA Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ginkgo Bioworks Holdings, Inc. (DNA) driven by superior Momentum & Technical, Options & Structure while STEM counters with relative strength in Growth & Margin. Fundamentally, STEM trades at N/M Forward P/E with -12.1% operating margin (-4.1% YoY revenue) versus DNA at N/M Forward P/E and -202.5% operating margin (-5.7% YoY). In options structure, STEM sits in BREAKDOWN (39th %ile IV; Dealer Gamma Walls on Pro) against DNA sits in BREAKDOWN (22nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
STEM N/M vs DNA N/M Fwd P/E
Growth & Margin Winner STEM
Op Margin -12.1% vs -202.5% ยท YoY -4.1% vs -5.7%
Momentum & Technical Winner DNA
1Y -95.8% vs -5.7% ยท 52W Pos 0% vs 16%
Options & Structure Winner DNA
BREAKDOWN (39th %ile IV) vs BREAKDOWN (22nd %ile IV)
STEM NYSE
Stem, Inc.
Miscellaneous Electrical Machinery, Equipment & Supplies
$0.64
-12.73% 1D
Market Cap $7.1M
1M Return -78.77%
1Y Return -95.84%
Forward P/E N/M
Unified AI Score
42.4 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 61.0 Mom 59.0
DNA NYSE
Ginkgo Bioworks Holdings, Inc.
Biological Products, (No Disgnostic Substances)
$7.46
-9.02% 1D
Market Cap $531.5M
1M Return -23.17%
1Y Return -5.69%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 45.0 Fund 56.0 Flow 68.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: STEM -95.84% DNA -5.69% Spread: +90.15 pp (DNA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period STEM Revenue DNA Revenue STEM Op. Margin DNA Op. Margin Margin Edge
FY2019 $20M $50M -272.6% -132.1% DNA
FY2020 $40M $80M -136.0% -178.8% STEM
FY2021 $130M $310M -65.2% -582.6% STEM
FY2022 $360M $480M -36.1% -462.4% STEM
FY2023 $460M $250M -38.9% -343.8% STEM
FY2024 $140M $230M -580.6% -246.5% DNA
FY2025 $160M $170M -35.6% -185.3% STEM

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: STEM (3) vs DNA (5)
Institutional Metric STEM DNA Criterion Row Winner
Market Capitalization Scale $7.1M $531.5M Larger Scale DNA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -4.1% -5.7% Higher Growth STEM
Operating Margin (TTM) Profitability -12.1% -202.5% Higher Margin STEM
Net Profit Margin Profitability -43.6% -192.0% Higher Margin STEM
Return on Equity (ROE) Capital Efficiency -5920.8% -58.2% Higher ROE DNA
52-Week Range Position Momentum 0% ($1โ€“$22) 16% ($5โ€“$18) Stronger Trend DNA
Beta / 30D Volatility Risk Regime 4.60ฮฒ ยท 234% Vol 3.12ฮฒ ยท 152% Vol Lower Realized Risk DNA
Unified Institutional Score Composite Signal 42.4 / 100 (HOLD) 52.1 / 100 (HOLD) Higher Composite DNA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full STEM vs DNA Buy Guide
STEM BREAKDOWN
145d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 39th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live STEM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DNA BREAKDOWN
34d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 22nd %ile
IV Regime Compressed (<25th %ile)
Live DNA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither STEM nor DNA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.